FDA inspection
Breckenridge Pharmaceutical, Inc.: FDA inspection ending Apr 22, 2009
FDA inspection 577532 · No Action Indicated (NAI) · Boca Raton, FL
Key facts
| Inspection ID | 577532 |
|---|---|
| Firm | Breckenridge Pharmaceutical, Inc. |
| FEI number | 3001829070 |
| Address | 6111 Broken Sound Pkwy NW Ste 170 |
| City | Boca Raton |
| State | FL |
| ZIP | 33487 |
| Country | United States |
| Fiscal year | 2009 |
| Inspection end date | Apr 22, 2009 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data